Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01774331 · ClinicalTrials.gov registry record
Gamma Globulin Observations and Outcomes Database for Specific Home Infusion Evidence, Patient Care And Research Data (GOOD-SHEPARD)
A clinical trial, sponsored by BriovaRx Infusion Services.
- Terminated
- Registry status
- 11
- Enrollment target
NCT01774331: Clinical Trial study, sponsored by BriovaRx Infusion Services.
NCT01774331 is a clinical trial that was terminated before completion, run by BriovaRx Infusion Services. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01774331 was terminated before completion, sponsored by BriovaRx Infusion Services.
- TERMINATED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Primary: • Demonstrate the utility of a new electronic data capture (EDC) system (CareExchange™) using infusion nurse measured physical, quality of life (QOL), respiratory, and disability assessments. Secondary: * Change in Intravenous Immunoglobulin (IVIg) dose effects measured outcomes. * Change in IVIg dose and timing effects measured outcomes. * Change in patient status is reflected in measured outcomes. * Assess the value to physicians from infusion nurse collected outcomes data. * Identify types of patients by response to IVIg therapy (i.e. natural or poor responders). * Change in response rate to IVIg therapy by disease state and demographics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2012-11 |
| Est. Completion | 2019-08 |
Why NCT01774331 stopped before completion
NCT01774331 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01774331 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01774331 about?
NCT01774331 is a clinical study titled "Gamma Globulin Observations and Outcomes Database for Specific Home Infusion Evidence, Patient Care And Research Data (GOOD-SHEPARD)". Primary: • Demonstrate the utility of a new electronic data capture (EDC) system (CareExchange™) using infusion nurse measured physical, quality of life (QOL), respiratory, and disability assessments. Secondary: * Change in Intravenous Immunoglobulin (IVIg) dose effects measured outcomes. * Chang...
What is the current status of trial NCT01774331?
This trial is currently terminated. The enrollment target is 11 participants. The study started on 2012-11. Estimated completion is 2019-08.
Who is sponsoring clinical trial NCT01774331?
This trial is sponsored by BriovaRx Infusion Services, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia